These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 18951760)
1. [C-peptide: a by-product of insulin biosynthesis or an active peptide hormone?]. Mavrakanas T; Bastide D Presse Med; 2009 Jan; 38(1):68-72. PubMed ID: 18951760 [No Abstract] [Full Text] [Related]
2. [Physiological effects of C-peptide]. Tsimaratos M Nephrologie; 2004; 25(5):155-61. PubMed ID: 15455788 [TBL] [Abstract][Full Text] [Related]
3. Ernst-Friedrich-Pfeiffer Memorial Lecture. New aspects of C-peptide physiology. Wahren J; Johansson BL Horm Metab Res; 1998 Jan; 30(1):A2-5. PubMed ID: 9503042 [TBL] [Abstract][Full Text] [Related]
4. [C-peptide physiological effects]. Shpakov AO; Granstrem OK Ross Fiziol Zh Im I M Sechenova; 2013 Feb; 99(2):196-211. PubMed ID: 23650733 [TBL] [Abstract][Full Text] [Related]
6. C-peptide: a new potential in the treatment of diabetic nephropathy. Wahren J; Ekberg K; Samnegård B; Johansson BL Curr Diab Rep; 2001 Dec; 1(3):261-6. PubMed ID: 12643208 [TBL] [Abstract][Full Text] [Related]
7. Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide. Sima AA J Neurol Sci; 2004 May; 220(1-2):133-6. PubMed ID: 15140622 [No Abstract] [Full Text] [Related]
8. [The clinical utility of C-peptide measurement in diabetology]. Otto-Buczkowska E Pediatr Endocrinol Diabetes Metab; 2015; 20(2):63-8. PubMed ID: 26615015 [TBL] [Abstract][Full Text] [Related]
9. [Perspective of new and future treatment of type 2 diabetes]. Sasaoka T Nihon Rinsho; 2012 May; 70 Suppl 3():707-15. PubMed ID: 22768603 [No Abstract] [Full Text] [Related]
13. Molecular and cellular effects of C-peptide--new perspectives on an old peptide. Wahren J; Shafqat J; Johansson J; Chibalin A; Ekberg K; Jörnvall H Exp Diabesity Res; 2004; 5(1):15-23. PubMed ID: 15198368 [TBL] [Abstract][Full Text] [Related]
14. [Maurice Dérot Prize 2004. Should C-peptide be put in the insulin bottle?]. Vague P Journ Annu Diabetol Hotel Dieu; 2004; ():231-7. PubMed ID: 15259321 [No Abstract] [Full Text] [Related]
15. Identifying latent autoimmune diabetes in adults in Korea: the role of C-peptide and metabolic syndrome. Lee SH; Kwon HS; Yoo SJ; Ahn YB; Yoon KH; Cha BY; Lee KW; Son HY Diabetes Res Clin Pract; 2009 Feb; 83(2):e62-5. PubMed ID: 19166794 [TBL] [Abstract][Full Text] [Related]
16. C-peptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Marx N; Walcher D; Raichle C; Aleksic M; Bach H; Grüb M; Hombach V; Libby P; Zieske A; Homma S; Strong J Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):540-5. PubMed ID: 14707040 [TBL] [Abstract][Full Text] [Related]
17. C-peptide: much more than a byproduct of insulin biosynthesis. Marques RG; Fontaine MJ; Rogers J Pancreas; 2004 Oct; 29(3):231-8. PubMed ID: 15367890 [TBL] [Abstract][Full Text] [Related]
18. C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment? Pinger CW; Entwistle KE; Bell TM; Liu Y; Spence DM Mol Biosyst; 2017 Jul; 13(8):1432-1437. PubMed ID: 28685788 [TBL] [Abstract][Full Text] [Related]
19. [C-peptide structure, functions and molecular mechanisms of action]. Shpakov AO; Granstrem AO Tsitologiia; 2013; 55(1):16-27. PubMed ID: 23662575 [TBL] [Abstract][Full Text] [Related]
20. The clinical potential of C-peptide replacement in type 1 diabetes. Wahren J; Kallas A; Sima AA Diabetes; 2012 Apr; 61(4):761-72. PubMed ID: 22442295 [No Abstract] [Full Text] [Related] [Next] [New Search]